These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1087912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL, Kupinski JM, Castella A, Ruggeri ZM.
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [Abstract] [Full Text] [Related]

  • 8. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K, Kubonishi I, Taguchi H, Miyoshi I.
    Acta Haematol; 1984 Nov; 71(3):158-64. PubMed ID: 6424380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD, Brockway WJ, Fass DN, Magnuson MA, Bowie EJ.
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [Abstract] [Full Text] [Related]

  • 11. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS, Meyer D, Dreyfus MD, Larrieu MJ.
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract] [Full Text] [Related]

  • 14. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P, Tamagnini GL, Dormandy KM.
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [Abstract] [Full Text] [Related]

  • 15. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D, Potter EV.
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [Abstract] [Full Text] [Related]

  • 16. Effect of somatostatin on platelet aggregation and plasma factor VIII level in normal man.
    Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J.
    Diabete Metab; 1977 Dec; 3(4):223-7. PubMed ID: 304425
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 19. Proceedings: Inhibition of human platelet aggregation by the proteolytic effect of streptokinase (SK). Role of the factor VIII related antigen.
    Castillo R, Maragall S, Guisasola JA, Casals F, Ruiz C, Ordinas A.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):574. PubMed ID: 1198469
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.